Esmolol - Revision history

Danbot: Switch SMW query from broadtable to table format for better layout with TOC

2026-03-20T21:55:30Z

Switch SMW query from broadtable to table format for better layout with TOC

2026-03-20T17:25:39Z

Fix SMW query: replace link=subject with mainlabel=- to fix broken subobject fragment links

2026-03-20T16:43:48Z

Add dynamic SMW Indications by Condition table (auto-populated from disease pages via MedicationDose template)

@@ Línea 45: / Línea 45: @@
 *Onset of action = 1-4min
 *Duration of action = <30min
 ==See Also==

2021-03-07T01:25:14Z

2020-11-21T22:02:52Z

Indications

← Revisión anterior		Revisión del 22:02 21 nov 2020
Línea 31:		Línea 31:
	==Indications==		==Indications==
	*Supraventricular arrhythmias		*Supraventricular arrhythmias
	*~~Blood Pressure~~ control in Symptomatic Aortic Aneurysm		*Heart rate and blood pressure control in Symptomatic Aortic Aneurysm (titrate to HR <60 bmp)
	*Off label use: refractory [[VF]]		*Off label use: refractory [[VF]]

2019-09-22T19:34:21Z

← Revisión anterior		Revisión del 19:34 22 sep 2019
Línea 17:		Línea 17:

	==Special Populations==		==Special Populations==
	*[[Drug Ratings in Pregnancy\|Pregnancy Rating]]:		*[[Drug Ratings in Pregnancy\|Pregnancy Rating]]: C
	*Lactation: Unknown if excreted in breast milk		*Lactation: Unknown if excreted in breast milk
	*Renal Dosing		*Renal Dosing
Línea 53:		Línea 53:

	[[Category:Pharmacology]]		[[Category:Pharmacology]]
			[[Category:Cardiology]]
			[[Category:Critical Care]]

2019-01-24T15:52:32Z

Indications

← Revisión anterior		Revisión del 15:52 24 ene 2019
Línea 9:		Línea 9:
	***If no response give another 500 bolus, increased infusion to 100		***If no response give another 500 bolus, increased infusion to 100
	***If no response give another 500 bolus, increased infusion to 200		***If no response give another 500 bolus, increased infusion to 200

			*Symptomatic AAA (controversial)
			**500mcg/kg bolus
			**Infusion of 50-200mcg/kg/min titrated to goal SBP

	==Pediatric Dosing==		==Pediatric Dosing==
Línea 14:		Línea 18:
	==Special Populations==		==Special Populations==
	*[[Drug Ratings in Pregnancy\|Pregnancy Rating]]:		*[[Drug Ratings in Pregnancy\|Pregnancy Rating]]:
	*Lactation:		*Lactation: Unknown if excreted in breast milk
	*Renal Dosing		*Renal Dosing
	**Adult		**Adult: No adjustment required
	**Pediatric
	*Hepatic Dosing		*Hepatic Dosing
	**Adult		**Adult: No adjustment required
	**Pediatric

	==Contraindications==		==Contraindications==
Línea 29:		Línea 31:
	==Indications==		==Indications==
	*Supraventricular arrhythmias		*Supraventricular arrhythmias
			*Blood Pressure control in Symptomatic Aortic Aneurysm
	*Off label use: refractory [[VF]]		*Off label use: refractory [[VF]]

Línea 36:		Línea 39:

	==Pharmacology==		==Pharmacology==
	*Half-life:		*Half-life: Adults - 9min Children 18mo-16yrs 2.7-4.8min
	*Metabolism:		*Metabolism: Red Blood Cell Esterase
	*Excretion:		*Excretion: Renal
	*Mechanism of Action: Class II - Short-acting Beta1 blocker		*Mechanism of Action: Class II - Short-acting Beta1 blocker
	*Onset of action = 1-4min		*Onset of action = 1-4min

2017-08-30T22:48:31Z

← Revisión anterior		Revisión del 22:48 30 ago 2017
Línea 2:		Línea 2:
	*Type: [[Beta blockers]]		*Type: [[Beta blockers]]
	*Dosage Forms:		*Dosage Forms:
	*Common Trade Names:		*Common Trade Names: Brevibloc

	==Adult Dosing==		==Adult Dosing==

2017-08-30T02:01:11Z

Indications

← Revisión anterior		Revisión del 02:01 30 ago 2017
Línea 29:		Línea 29:
	==Indications==		==Indications==
	*Supraventricular arrhythmias		*Supraventricular arrhythmias
			*Off label use: refractory [[VF]]

	==Adverse Reactions==		==Adverse Reactions==

2017-07-13T06:32:39Z

← Revisión anterior		Revisión del 01:25 7 mar 2021
Línea 47:		Línea 47:

	==See Also==		==See Also==
			*[[Beta-blockers]]
			*[[Beta-blocker toxicity]]
	*[[Antiarrhythmics]]		*[[Antiarrhythmics]]
			*[[Antihypertensive medications]]

	==References==		==References==